Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann Vandevoorde

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Clinical Pharmacology|November 9, 2013
The effect of rilpivirine on the pharmacokinetics of methadone in HIV-negative volunteersHerta M Crauwels, Rolf P G van Heeswijk, Ann Vandevoorde, et al.
Antimicrobial Agents and Chemotherapy|March 13, 2013
Pharmacokinetic interaction between telaprevir and methadoneRolf van Heeswijk, Peter Verboven, Ann Vandevoorde, et al.
Health Science Reports|April 10, 2020
Simeprevir, daclatasvir, and sofosbuvir for hepatitis C virus-infected patients: Long-term follow-up results from the open-label, Phase II IMPACT studyEric Lawitz, Fred Poordad, Julio A Gutierrez, et al.
Current HIV Research|February 21, 2012
Week 96 efficacy, virology and safety of darunavir/r versus lopinavir/r in treatment-experienced patients in TITANDénes Bánhegyi, Christine Katlama, Clóvis Arns da Cunha, et al.
Journal of Clinical Pharmacology|May 16, 2015
Pharmacokinetic interaction between etravirine or rilpivirine and telaprevir in healthy volunteers: A randomized, two-way crossover trialThomas N Kakuda, Lorant Leopold, Steven Nijs, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Clinical Pharmacology|November 9, 2013
The effect of rilpivirine on the pharmacokinetics of methadone in HIV-negative volunteersHerta M Crauwels, Rolf P G van Heeswijk, Ann Vandevoorde, et al.
Antimicrobial Agents and Chemotherapy|March 13, 2013
Pharmacokinetic interaction between telaprevir and methadoneRolf van Heeswijk, Peter Verboven, Ann Vandevoorde, et al.
Health Science Reports|April 10, 2020
Simeprevir, daclatasvir, and sofosbuvir for hepatitis C virus-infected patients: Long-term follow-up results from the open-label, Phase II IMPACT studyEric Lawitz, Fred Poordad, Julio A Gutierrez, et al.
Current HIV Research|February 21, 2012
Week 96 efficacy, virology and safety of darunavir/r versus lopinavir/r in treatment-experienced patients in TITANDénes Bánhegyi, Christine Katlama, Clóvis Arns da Cunha, et al.
Journal of Clinical Pharmacology|May 16, 2015
Pharmacokinetic interaction between etravirine or rilpivirine and telaprevir in healthy volunteers: A randomized, two-way crossover trialThomas N Kakuda, Lorant Leopold, Steven Nijs, et al.
Pageof 1